FDA Orphan Drug Designation for a New Neuroendocrine Tumor Treatment!
source: pixabay.com

FDA Orphan Drug Designation for a New Neuroendocrine Tumor Treatment!

Neuroendocrine tumors are growths which form from neuroendocrine cells in various places throughout the body. They can occur in the gastrointestinal track, the pancreas, the lungs, the thymus, and other…

Continue Reading FDA Orphan Drug Designation for a New Neuroendocrine Tumor Treatment!
This Jewish Australian Teenager With Gaucher Disease Just Launched a Support Group for Patients
source: pixabay.com

This Jewish Australian Teenager With Gaucher Disease Just Launched a Support Group for Patients

According to a story from the Australian Jewish News, a Jewish teen named Gidon Goodman was born with Gaucher disease. Recently, he started the first Gaucher disease patient support group…

Continue Reading This Jewish Australian Teenager With Gaucher Disease Just Launched a Support Group for Patients
Data From a Phase 2 Nonalcoholic Fatty Liver Disease Trial Looks Promising
luvqs / Pixabay

Data From a Phase 2 Nonalcoholic Fatty Liver Disease Trial Looks Promising

According to a story from tradeshownews.vporoom.com, the biopharmaceutical company Viking Therapeutics, Inc., has recently released the results from a Phase 2 clinical trial. This trial is testing the company's investigational therapeutic…

Continue Reading Data From a Phase 2 Nonalcoholic Fatty Liver Disease Trial Looks Promising
Participants in a Duchenne Muscular Dystrophy Clinical Trial Found out the Drug Wasn’t Working on Social Media
source: pixabay.com

Participants in a Duchenne Muscular Dystrophy Clinical Trial Found out the Drug Wasn’t Working on Social Media

According to a story from nature.com, Amber Sapp's twelve year old son Garrett had been participating in a clinical trial that was testing a new potential treatment for his Duchenne…

Continue Reading Participants in a Duchenne Muscular Dystrophy Clinical Trial Found out the Drug Wasn’t Working on Social Media
Gene Therapy for Fanconi Anemia Gains IND Clearance From the FDA
https://pixabay.com/en/dna-microscopic-cell-gene-helix-1903319/

Gene Therapy for Fanconi Anemia Gains IND Clearance From the FDA

According to a story from BioSpace, the gene therapy company Rocket Pharma recently announced that its investigational product candidate RP-L102 recently saw its Investigational New Drug (IND) application gain approval…

Continue Reading Gene Therapy for Fanconi Anemia Gains IND Clearance From the FDA
$1.4 Million Donated to Help Bring a Gene Therapy For Tay-Sachs Disease to Clinical Trial
felixioncool / Pixabay

$1.4 Million Donated to Help Bring a Gene Therapy For Tay-Sachs Disease to Clinical Trial

A $1.4 million dollar donation to the University of Massachusetts Medical School will help to fund research into a gene therapy for Tay-Sachs disease as it transitions from pre-clinical to…

Continue Reading $1.4 Million Donated to Help Bring a Gene Therapy For Tay-Sachs Disease to Clinical Trial
Proof of Concept Data Highlights Viability of Gene Therapy for Metachromatic Leukodystrophy
source: pixabay.com

Proof of Concept Data Highlights Viability of Gene Therapy for Metachromatic Leukodystrophy

According to a story from Market Screener, the genetic medicines company Homology Medicines, Inc., recently announced the presentation of data which revealed that the company's proprietary virus vectors, which are…

Continue Reading Proof of Concept Data Highlights Viability of Gene Therapy for Metachromatic Leukodystrophy